Senior Global Access Evidence Leader - EU HTA Statistician

Roche Holding AG; Basel; Vor Ort; CHF 180.000 - 240.000; Vollzeit

Zusammenfassung

Roche Holding AG recherche un Senior Global Access Evidence Leader pour diriger les stratégies EU HTA et les soumissions associées. Vous contribuerez à transformer des découvertes scientifiques en solutions de soins, en guidant des analyses statistiques avancées et des packages de preuves adaptés aux marchés européens.

Le poste nécessite une expérience étendue en HTA européenne, des compétences en NMA et EHR, ainsi qu’un leadership collaboratif capable de fédérer des équipes transverses et de

Qualifikationen

• Master's ou Doctorat en statistiques appliquées.
• 12+ années d'expérience dans l'industrie pharmaceutique, HTA/economie de la santé, ou recherche académique.
• Réseau établi en HTA européen et relations avec les parties prenantes.

Aufgaben

• Mener la stratégie et les soumissions EUHTA et définir les analyses de preuve.
• Innover méthodologiquement dans les contextes européens et influencer les cadres EU HTA.
• Concevoir des packages de preuves régionisés et narratives pour les payeurs.
• Encadrer les équipes transverses et dialoguer avec les autorités et organes HTA.
• Conduire des analyses statistiques complexes y compris NMA et EHR synthèse.

Kenntnisse

EU HTA expertise

Advanced statistics

Network Meta-Analysis

Real‑world evidence analyses

R

Python

SAS

English proficiency

German/French language skills (plus)

Ausbildung

Master's/Doctoral degree in applied statistics

Tools

R

Python

SAS

GitLab

WinBUGS/JAGS

Jobbeschreibung

Chez Roche, vous pouvez être vous-même et être apprécié pour les qualités uniques que vous apportez. Notre culture encourage l'expression personnelle, le dialogue ouvert et les connexions authentiques, où vous êtes valorisé, accepté et respecté pour ce que vous êtes, vous permettant de prospérer tant personnellement que professionnellement. Voici comment nous visons à prévenir, arrêter et guérir les maladies et à garantir à chacun l'accès aux soins de santé aujourd'hui et pour les générations à venir. Rejoignez Roche, où chaque voix compte.

La position

Our Global Pharma Strategy (GPS) team plays a pivotal role in shaping the future of healthcare by driving the strategic direction of our innovative product portfolio. As a member of the GPS team, you will be at the forefront of transforming groundbreaking scientific discoveries into accessible and impactful healthcare solutions for patients worldwide. We are seeking a dynamic and visionary senior professional who thrives in a collaborative environment and is passionate about making a difference.

Within GPS, the Global Access (GA) department is dedicated to delivering sustainable, replicable, and scalable global strategies, policies, and solutions. Our mission is to support the Pharma Vision, enabling affiliates to drive patient access locally while improving value for society, healthcare ecosystems, and Roche’s business. We operate in a highly networked and agile model with stable chapters and flexible squads and work teams across the product lifecycle, disease areas, functions, and geographies, with chapters built around the expertise and capabilities needed to co-create and deliver integrated solutions.

Role Overview

We are seeking a dynamic and visionary Senior Global Access Evidence Leader with deep EU HTA and advanced statistical and evidence-synthesis expertise to join our Evidence Chapter—a professional recognized within the European HTA community for advancing evidence standards and shaping submissions that secure patient access across EU member states. In this role, you will thrive in a collaborative environment and be passionate about making a difference.

The Opportunity

• Lead EU HTA evidence strategy: Shape Roche's approach to EU HTA submissions by embedding sophisticated, anticipatory evidence strategies into clinical development from inception, ensuring alignment with EMA regulations, and the new EU HTA regulations. Position us as a benchmark for evidence excellence across European markets.
• Drive methodological innovation in EU contexts: Leverage your established networks within European HTA bodies, payers, and health authorities to advance evidence standards and best practices—influencing how the industry approaches submissions to national HTA organizations and contributing to the evolution of EU HTA frameworks.
• Architect compelling EU submissions: Design innovative, region-specific evidence packages that anticipate the needs of EMA committees, HTA bodies and national payers. Identify strategic evidence gaps early, pioneer novel data sources and analyses, and translate complex statistical findings into narratives that drive reimbursement and access decisions across EU markets.
• Establish Roche as an EU HTA expert: Leverage your reputation and deep relationships within the European Access/HTA ecosystem to elevate submission quality, engage proactively with key opinion leaders and HTA bodies, and position Roche as a thought leader in EU evidence generation and submission strategy.
• Lead strategic statistical analysis for EU evidence packages: Lead and critically evaluate complex statistical analyses—including network meta-analyses and real-world evidence syntheses—ensuring methodological rigor and compliance with EU HTA requirements while translating findings into compelling, region-appropriate narratives.
• Enable affiliates and cross-functional teams: Guide European affiliate teams and cross-functional partners in building robust EU submission strategies, ensure alignment across EMA development pathways and national HTA submissions, and mentor colleagues on evolving EU regulatory and HTA landscapes.
• Contribute to EU HTA evolution: Maintain influential engagement with European HTA bodies, regulatory agencies, and academic networks—actively participating in professional forums, contributing to methodological debates, and ensuring Roche remains at the forefront of EU evidence standards and innovation.

Who You Are

• Advanced expertise & experience in EU HTA: You hold a Master's or Doctoral-level degree in applied statistics and bring 12+ years of deep, hands‑on experience in the pharmaceutical industry, health economics/HTA consultancy, European payer organizations, EMA‑regulated environments, or academic research with progressive strategic influence in European markets.
• Recognized standing in the European HTA community: You are a known voice actively engaged with European HTA networks, national HTA bodies, or equivalent professional networks, holding established relationships with key opinion leaders and contributing to methodological discussions through publications, conference presentations, or advisory roles.
• Deep knowledge of the EU HTA landscape: You demonstrate a thorough understanding of the EU HTA Regulation (2021/2282) and joint clinical assessment procedures, national HTA requirements across major European markets (UK, Germany, France, Italy, Spain, etc.), EMA scientific advice and conditional approval pathways, and real‑world evidence requirements in EU contexts.
• Master-level statistical expertise & strategic vision: You possess mastery of advanced statistical methods (Generalized Linear Models, Survival Analysis, Network Meta-Analysis, Bayesian methods, real‑world evidence analyses) using R and contemporary tools (GitLab, SAS, Python, WinBUGS, JAGS), paired with the ability to think strategically about EU market access and nuances across European healthcare systems.
• Collaborative leadership & exceptional communication: You excel at leading cross‑functional teams in matrix environments, engaging with European affiliate teams and external HTA bodies, and possess outstanding written and verbal communication skills in English (and ideally German, French, or other European languages) to translate technical analyses into compelling narratives.

Qui nous sommes

Un avenir plus sain nous pousse à innover. Ensemble, plus de 100 000 employés à travers le monde sont dédiés à faire progresser la science et à garantir à chacun l'accès aux soins de santé aujourd'hui et pour les générations à venir. Nos efforts aboutissent à plus de 26 millions de personnes traitées avec nos médicaments et plus de 30 milliards de tests réalisés avec nos produits de Diagnostique. Nous nous encourageons mutuellement à explorer de nouvelles possibilités, à favoriser la créativité et à conserver nos grandes ambitions, afin de fournir des solutions de santé qui changent des vies et ont un impact mondial.

Construisons ensemble un avenir plus sain.

Roche est un employeur offrant l'équité en matière d'emploi.